The traditional model of reactive medicine, where patients only seek care after symptoms become unbearable, is rapidly being replaced by a sophisticated ecosystem of continuous physiological monitoring. Instead of relying on sporadic clinic visits that offer only a momentary snapshot of health, the
When a manufacturer responsible for critical medical device components experiences a total halt in its digital operations, the consequences ripple far beyond the walls of its corporate headquarters and into the healthcare facilities that rely on its timely deliveries. UFP Technologies, a prominent
In the high-stakes environment of cardiac care, where precision instruments can mean the difference between life and death, the reliability of medical technology is paramount. A significant safety concern has now emerged surrounding a critical device, as Johnson & Johnson's subsidiary, Abiomed,
We're joined today by James Maitland, a leading expert in medical robotics and IoT applications, whose work focuses on integrating advanced technology safely and effectively into healthcare. With the explosion of generative AI, the healthcare sector faces a dual reality: unprecedented opportunity
A Regulatory Standoff with High Stakes In a move that sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) has taken the extraordinary step of refusing to conduct a formal review of Moderna's biologics license application for its mRNA-based influenza
In a surprising display of resilience, the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) not only maintained its operational tempo but also increased its authorization of novel medical devices in 2025, a period marked by significant staff reductions under the
